750 results match your criteria: "Hospital "San Giovanni Bosco"[Affiliation]"
Kidney Int Rep
October 2024
University Center of Excellence on Nephrological, Rheumatological and Rare Diseases (ERK-net, ERN-Reconnet and RITA-ERN Member) Including Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley (North-West Italy), San Giovanni Bosco Hub Hospital, ASL Città di Torino and Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy.
Rheumatology (Oxford)
October 2024
University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.
Eur Heart J Qual Care Clin Outcomes
October 2024
Division of Cardiology, Cardiovascular and Thoracic Department, "Città della Salute e della Scienza" Hospital, Corso Bramante 88, 10126 Turin, Italy.
Background: Despite evidence supporting use of fractional flow reserve (FFR) and instantaneous waves-free ratio (iFR) to improve outcome of patients undergoing coronary angiography (CA) and percutaneous coronary intervention, such techniques are still underused in clinical practice due to economic and logistic issues.
Objectives: We aimed to develop an artificial intelligence (AI)-based application to compute FFR and iFR from plain CA.
Methods And Results: Consecutive patients performing FFR or iFR or both were enrolled.
J Nephrol
October 2024
Department of Nephrology, Bassini Hospital, Cinisello Balsamo, Italy.
Background: Systemic steroids are recommended for patients with IgA nephropathy (IgAN) and proteinuria. However, there are concerns about their safety due to an excess of serious adverse events (SAEs) in previous randomised trials. This study evaluates the incidence of SAEs in IgAN patients receiving different treatment regimens in clinical practice.
View Article and Find Full Text PDFIntensive Care Med
November 2024
Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital, Paris, France.
The European Society of Intensive Care Medicine (ESICM) has developed evidence-based recommendations and expert opinions about end-of-life (EoL) and palliative care for critically ill adults to optimize patient-centered care, improving outcomes of relatives, and supporting intensive care unit (ICU) staff in delivering compassionate and effective EoL and palliative care. An international multi-disciplinary panel of clinical experts, a methodologist, and representatives of patients and families examined key domains, including variability across countries, decision-making, palliative-care integration, communication, family-centered care, and conflict management. Eight evidence-based recommendations (6 of low level of evidence and 2 of high level of evidence) and 19 expert opinions were presented.
View Article and Find Full Text PDFInt J Cardiol
January 2025
Division of Cardiology-1, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Background: The clinical governance of patients with acute myocardial infarction (AMI) has markedly changed in the last few years. We sought to assess the contemporary in-hospital management patterns of patients with AMI at a country level.
Methods: EYESHOT (EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units)-2 was a nationwide, prospective registry aimed to evaluate the current management of patients admitted to intensive cardiac care units (CCUs) for an AMI in Italy.
Eur J Pain
September 2024
Rheumatology Unit, Dipartimento di Scienze Cliniche e Molecolari, Università Politecnica Delle Marche, Ancona, Italy.
Background: Geographic origin may represent a variable capable of influencing health status. This study aims to investigate the presence of differences of disease severity in Italian patients with fibromyalgia from different macro-regions.
Methods: This retrospective, cross-sectional study involved patients included in the Italian Fibromyalgia Registry.
Front Immunol
September 2024
University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital ASL Città di Torino and Department of Clinical and Biological Sciences, Turin, Italy.
Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening condition of small-vessel thrombosis with acute multiple-organ involvement and visceral damage. In this report, we present a case of a patient with CAPS who is refractory to conventional therapy. For the first time in a patient with CAPS, marked C5b-9 formation was demonstrated on microvascular endothelial cells, suggesting the usefulness of therapeutic complement inhibition in this setting.
View Article and Find Full Text PDFInt J Cardiol
January 2025
Cardiac Intensive Care Unit, "De Gasperis Cardio Center", ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Ann Emerg Med
October 2024
Department of Emergency Medicine, San Giovanni Bosco Hospital, Torino, Italy.
J Bioeth Inq
September 2024
Schumacher College, Totnes, UK.
In the last decade literature focused on a "less is more" approach has been primarily represented by clinical cases describing the excesses of an aggressive, redundant, non-personalized, and non-respectful medicine. Most of these articles focus on a "more is worse" approach and centre around the downstream negative consequences of medical overuse. Having identified a gap in the literature on the experience and practice of less, rather than the harms of excess, we carried out an exploratory qualitative study into how a "less is more" approach works in practice.
View Article and Find Full Text PDFKidney360
November 2024
Onconephrology Outpatient Clinic, Nephrology and Dialysis Unit, ASST Fatebenefratelli Sacco, Milan, Italy.
Molecular targeted therapy has revolutionized cancer treatment by significantly improving patient survival compared with standard conventional chemotherapies. The use of these drugs targets specific molecules or targets, which block growth and spread of cancer cells. Many of these therapies have been approved for use with remarkable success in breast, blood, colorectal, lung, and ovarian cancers.
View Article and Find Full Text PDFCardiovasc Revasc Med
August 2024
Division of Cardiology, Interventional Unit - Infermi Rivoli Hospital, Rivoli (Turin), Italy and San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.
Front Oncol
August 2024
General Thoracic Surgery, Dokkyo Medical University, Mibu, Japan.
Med Clin (Barc)
August 2024
Laboratory of Immunology and Allergy, San Giovanni di Dio Hospital, Florence, Italy.
Antiphospholipid antibodies (aPL) are a family of autoantibodies targeting phospholipid-binding proteins and are associated with several clinical settings, and most notably define the antiphospholipid syndrome (APS). These antibodies can be identified using a variety of laboratory tests, which include both solid-phase immunological assays and functional clotting assays that detect lupus anticoagulants (LA). aPLs are linked to a range of adverse medical conditions, such as thrombosis and complications affecting the placenta and fetus, potentially leading to morbidity and mortality.
View Article and Find Full Text PDFEur Stroke J
August 2024
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Introduction: Endovascular treatment (EVT) improves outcomes for basilar artery occlusion (BAO) with moderate-to-severe symptoms. However, the best treatment for mild symptoms (NIHSS score 0-10 and 0-5) remains unclear. This study compared EVT ± IVT to IVT alone in BAO patients with mild symptoms.
View Article and Find Full Text PDFFront Cardiovasc Med
July 2024
UOC Diagnostica Interventistica, Ospedale del Cuore Fondazione C.N.R. Regione Toscana G. Monasterio Massa, Massa, Italy.
Introduction: Recent studies have shown gender differences in cardiovascular outcomes after left atrial appendage closure (LAAC), highlighting different complication rates and adverse events, particularly in short-term assessments. As a result, there remains a significant knowledge gap on how these differences directly impact the efficacy and safety of LAAC procedures. The aim of this retrospective study was to investigate the clinical outcomes of LAAC in women and men using the Watchman FLX device.
View Article and Find Full Text PDFArthritis Care Res (Hoboken)
December 2024
Hospital for Special Surgery, Weill Cornell Medicine, New York City, New York.
Eur J Heart Fail
November 2024
Department of Clinical-Surgical, Diagnostic and Paediatric Sciences University of Pavia, Pavia, Italy.
Aims: To describe the use and the relation to outcome of different ventilation strategies in a contemporary, large, prospective registry of cardiogenic shock patients.
Methods And Results: Among 657 patients enrolled from March 2020 to November 2023, 198 (30.1%) received oxygen therapy (OT), 96 (14.
J Vasc Access
August 2024
Renal, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari, Bari, Italy.
The Renal Expert in Vascular Access (REVAC) is one of the four modules of the Nephrology Partnership for Advancing Technology in Healthcare (N-PATH) project, the first European-wide advanced training course in diagnostics and interventional nephrology, funded by Erasmus+ Knowledge Alliance, a European Commission program. The N-PATH primary goal was to train 40 young European nephrologists in both theoretical knowledge and practical skills related to interventional nephrology. The REVAC module focused on the crucial aspects of vascular access (VA) care in nephrology practice, as a complementary training path to the actual residency program.
View Article and Find Full Text PDFRadiol Med
September 2024
Department of Radiology and Neuroradiology, San Giovanni Bosco Hospital, Piazza Donatore di Sangue 3, 10154, Turin, Italy.
J Anesth Analg Crit Care
July 2024
Department of Anesthesiology, Critical Care Medicine and Emergency, SS. Annunziata Hospital, Chieti, Italy.
J Infect Dev Ctries
July 2024
U.O.C. di Medicina Generale e Lungodegenza, San Giovanni Bosco Hospital, ASL Na1 Centro, Naples, Italy.
Introduction: We report the case of a 76-year-old male who was hospitalized with severe dehydration, pain in the hepatic region, and weakness in the limbs.
Methodology: A contrast-enhanced abdomen CT and a contrast-enhanced ultrasound identified a large liver abscess. The patient underwent percutaneous drainage of the abscess.
Autoimmun Rev
September 2024
Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine, University of Rome "Campus Bio-Medico", 00128 Rome, Italy; Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy.
Inflammatory rheumatic diseases are different pathologic conditions associated with a deregulated immune response, codified along a spectrum of disorders, with autoinflammatory and autoimmune diseases as two-end phenotypes of this continuum. Despite pathogenic differences, inflammatory rheumatic diseases are commonly managed with a limited number of immunosuppressive drugs, sometimes with partial evidence or transferring physicians' knowledge in different patients. In addition, several randomized clinical trials, enrolling these patients, did not meet the primary pre-established outcomes and these findings could be linked to the underlying molecular diversities along the spectrum of inflammatory rheumatic disorders.
View Article and Find Full Text PDF